Subsequently, a codon-optimized TCR was generated from these clones, and adoptive transfer of NPM1/HLA-A*02:01-specific TCR-transduced T cells specifically killed both AML cell lines and primary AML blasts and controlled tumor outgrowth and prolonged survival in a xenograft model (44). Here, HLA-A is linked to acute myeloid leukemia.